Paschalis Evangelidis/LinkedIn
Jul 9, 2026, 12:19
Paschalis Evangelidis: Join Our Special Issue on Thrombosis and Vascular Disorders
Paschalis Evangelidis, Medical Doctor, Former Teaching Assistant at Aristotle University of Thessaloniki (AUTH), shared a post on LinkedIn:
“We would like to share that the submission deadline for our Special Issue in Pharmaceuticals MDPI has been extended to 25 January 2027.
We warmly welcome contributions from colleagues working on thrombosis, thrombotic microangiopathies, endothelial injury syndromes, cardiovascular disease, inflammation, and related scientific fields.
More information is available here.”
Stay updated with Hemostasis Today.
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:30Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF
-
Oct 12, 2026, 21:28Michael Megaly: Does Coronary Ectasia Affect Outcomes in Acute Coronary Syndromes?
-
Oct 12, 2026, 21:25Vitor Borin P. de Souza: Think Twice Before Anticoagulating an Isolated Subsegmental PE
-
Oct 12, 2026, 20:43Jazlyn A Selvasingh: Excited to Share Our Research at AAO-HNSF 2026 in Los Angeles
-
Oct 12, 2026, 20:31Natalia Kovtun: Higher Ferritin Cutoffs Now Define Iron Deficiency
-
Oct 12, 2026, 19:39Edward Loftus: Using Low-Dose Aspirin in Pregnant Women With IBD
-
Oct 12, 2026, 19:32Shruti Sachdeva: Strengthening the Fight against Anemia